Notably, Sauer et al. (34) reported the first structure of human sodium-dependent citrate transporter NaCT and revealed the substrate and inhibitor bound inward facing conformation, providing an important clue to optimize the anti-obesity drugs. The gene discussed is SLC13A5; the disease is Obesity.